• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用尿液、血浆和唾液中的表型分析方法研究[具体物质]对[具体酶]活性的影响。 (注:原文中部分内容缺失,此为补充完整关键信息后的翻译)

The impact of on enzyme activity using phenotyping methods in urine, plasma, and saliva.

作者信息

Jin Ye, Zhang Shuquan, Hu Pei, Zheng Xin, Guan Xiaoduo, Chen Rui, Zhang Shuyang

机构信息

State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.

Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.

出版信息

Front Pharmacol. 2022 Aug 30;13:940510. doi: 10.3389/fphar.2022.940510. eCollection 2022.

DOI:10.3389/fphar.2022.940510
PMID:36110554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9468644/
Abstract

The variant is the second or third frequent reduced function allele in Chinese with a frequency of around 3-4%, while it is the major reduced function allele in Indians, Saudi Arabians and Caucasians with frequencies of around 10-20%. The present study was designed to explore the impact of on the metabolic activity of using phenotyping methods in urine, plasma, and saliva. We used dextromethorphan as the probe drug to analyze the phenotypes of 87 subjects with / ( = 22), / ( = 33), / ( = 4), / ( = 5), / ( = 3), / ( = 16), and / ( = 4) for . The ratio of parent drug to metabolite in 3 h saliva, 3 h plasma, and in 0-3 h urine was considered the metabolic ratio (MR). The allele had substantial impact on the metabolic activity of regardless of the urinary, plasma, or salivary phenotyping method used. In subjects with (or )/(or ), (or )/, / and / (all < 0.001), the salivary, plasma, or urinary MR value increased. The MRs in saliva, plasma, and urine displayed high correlations. The activity score system or the consensus activity score system, instead of the traditional phenotype classification, could predict the enzyme activity more accurately. had similar or more impact on the enzyme activity as compared with . Assigning a score of 0.5 and assigning a score of 0.25 according to the consensus AS system should be reconsidered.

摘要

该变体是中国人中第二或第三常见的功能降低等位基因,频率约为3%-4%,而在印度人、沙特阿拉伯人和高加索人中,它是主要的功能降低等位基因,频率约为10%-20%。本研究旨在通过尿液、血浆和唾液的表型分析方法,探讨其对代谢活性的影响。我们使用右美沙芬作为探针药物,分析了87名具有/(=22)、/(=33)、/(=4)、/(=5)、/(=3)、/(=16)和/(=4)基因型受试者的表型。3小时唾液、3小时血浆和0-3小时尿液中母体药物与代谢物的比率被视为代谢率(MR)。无论使用尿液、血浆还是唾液表型分析方法,等位基因对的代谢活性都有显著影响。在具有(或)/(或)、(或)/、/和/(均<0.001)的受试者中,唾液、血浆或尿液MR值升高。唾液、血浆和尿液中的MR显示出高度相关性。活性评分系统或共识活性评分系统,而非传统的表型分类,能够更准确地预测酶活性。与相比,对酶活性具有相似或更大的影响。根据共识AS系统,将的评分设为0.5,将的评分设为0.25,这一点应重新考虑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0063/9468644/52f91e43765c/fphar-13-940510-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0063/9468644/3ba84492d761/fphar-13-940510-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0063/9468644/fdced5723072/fphar-13-940510-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0063/9468644/52f91e43765c/fphar-13-940510-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0063/9468644/3ba84492d761/fphar-13-940510-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0063/9468644/fdced5723072/fphar-13-940510-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0063/9468644/52f91e43765c/fphar-13-940510-g003.jpg

相似文献

1
The impact of on enzyme activity using phenotyping methods in urine, plasma, and saliva.使用尿液、血浆和唾液中的表型分析方法研究[具体物质]对[具体酶]活性的影响。 (注:原文中部分内容缺失,此为补充完整关键信息后的翻译)
Front Pharmacol. 2022 Aug 30;13:940510. doi: 10.3389/fphar.2022.940510. eCollection 2022.
2
Phenotyping Using Urine, Plasma, and Saliva Metabolic Ratios to Assess the Impact of on Interindividual Variation in a Chinese Population.利用尿液、血浆和唾液代谢物比率进行表型分析,以评估[具体因素]对中国人群个体间差异的影响。
Front Pharmacol. 2017 May 2;8:239. doi: 10.3389/fphar.2017.00239. eCollection 2017.
3
Novel single-point plasma or saliva dextromethorphan method for determining CYP2D6 activity.用于测定CYP2D6活性的新型单点血浆或唾液右美沙芬方法。
J Pharmacol Exp Ther. 1998 Jun;285(3):955-60.
4
Determination of dextromethorphan metabolic phenotype by salivary analysis with a reference to genotype in Chinese patients receiving renal hemodialysis.通过唾液分析并参考接受肾脏血液透析的中国患者的基因型来确定右美沙芬代谢表型。
Clin Pharmacol Ther. 1996 Apr;59(4):411-7. doi: 10.1016/S0009-9236(96)90109-5.
5
Serum dextromethorphan/dextrorphan metabolic ratio for CYP2D6 phenotyping in clinical practice.临床实践中用于 CYP2D6 表型分析的血清右美沙芬/去甲右美沙芬代谢比值。
J Clin Pharm Ther. 2012 Aug;37(4):486-90. doi: 10.1111/j.1365-2710.2012.01333.x. Epub 2012 May 1.
6
Alternative methods for CYP2D6 phenotyping: comparison of dextromethorphan metabolic ratios from AUC, single point plasma, and urine.CYP2D6 表型分析的替代方法:比较来自AUC、单点血浆和尿液的右美沙芬代谢率
Int J Clin Pharmacol Ther. 2016 May;54(5):330-6. doi: 10.5414/CP202387.
7
Effect of gender, sex hormones, time variables and physiological urinary pH on apparent CYP2D6 activity as assessed by metabolic ratios of marker substrates.通过标记底物的代谢比评估性别、性激素、时间变量和生理性尿pH对表观CYP2D6活性的影响。
Pharmacogenetics. 2000 Jul;10(5):425-38. doi: 10.1097/00008571-200007000-00006.
8
Comparison of various urine collection intervals for caffeine and dextromethorphan phenotyping in children.儿童咖啡因和右美沙芬表型分析中不同尿液收集间隔的比较。
J Clin Pharmacol. 2004 Jul;44(7):708-14. doi: 10.1177/0091270004266624.
9
Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians.沙特阿拉伯人群中CYP2D6基因重复现象频繁发生。
Pharmacogenetics. 1997 Jun;7(3):187-91. doi: 10.1097/00008571-199706000-00003.
10
Metabolic capacity of CYP2D6 within an Iranian population (Mazandaran Province).伊朗人群(马赞德兰省)中CYP2D6的代谢能力。
Caspian J Intern Med. 2011 Spring;2(2):213-7.

引用本文的文献

1
Distribution of Cytochrome P450 2D6 (*4, *9, *10, *41) alleles in healthy population from north-west of Iran.伊朗西北部健康人群中细胞色素P450 2D6(*4、*9、*10、*41)等位基因的分布情况。
ARYA Atheroscler. 2025;21(2):33-42. doi: 10.48305/arya.2025.42811.2980.
2
The CYP2D6 phenotyping performance of single-point saliva metabolic ratio in a healthy Chinese Han population.单点唾液代谢率在健康中国汉族人群中对CYP2D6的表型分析性能
Front Pharmacol. 2025 Feb 21;16:1438760. doi: 10.3389/fphar.2025.1438760. eCollection 2025.
3
Case report: Avoiding intolerance to antipsychotics through a personalized treatment approach based on pharmacogenetics.

本文引用的文献

1
Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P-Glycoprotein Activities.液体活检在心血管疾病患者特征分析中的应用:与细胞色素 P450 和 P-糖蛋白活性标志物的验证比较。
Clin Pharmacol Ther. 2022 Jun;111(6):1268-1277. doi: 10.1002/cpt.2576. Epub 2022 Mar 28.
2
Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group.标准化 CYP2D6 基因型到表型的转化:临床药物基因组学实施联盟和荷兰药物基因组学工作组的共识建议。
Clin Transl Sci. 2020 Jan;13(1):116-124. doi: 10.1111/cts.12692. Epub 2019 Oct 24.
3
病例报告:通过基于药物遗传学的个性化治疗方法避免对抗精神病药物不耐受
Front Psychiatry. 2024 Mar 19;15:1363051. doi: 10.3389/fpsyt.2024.1363051. eCollection 2024.
Interrogation of CYP2D6 Structural Variant Alleles Improves the Correlation Between CYP2D6 Genotype and CYP2D6-Mediated Metabolic Activity.
CYP2D6 结构变异等位基因的检测提高了 CYP2D6 基因型与 CYP2D6 介导的代谢活性之间的相关性。
Clin Transl Sci. 2020 Jan;13(1):147-156. doi: 10.1111/cts.12695. Epub 2019 Oct 25.
4
Resequencing gene in Indian population: identified as the major reduced function allele.对印度人群中的基因进行重测序:鉴定为主要的功能降低等位基因。
Pharmacogenomics. 2019 Jul;20(10):719-729. doi: 10.2217/pgs-2019-0049. Epub 2019 Aug 1.
5
Phenotyping Using Urine, Plasma, and Saliva Metabolic Ratios to Assess the Impact of on Interindividual Variation in a Chinese Population.利用尿液、血浆和唾液代谢物比率进行表型分析,以评估[具体因素]对中国人群个体间差异的影响。
Front Pharmacol. 2017 May 2;8:239. doi: 10.3389/fphar.2017.00239. eCollection 2017.
6
Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.临床药物基因组学实施联盟指南(CPIC):CYP2D6 和 CYP2C19 基因型与三环类抗抑郁药剂量:2016 年更新。
Clin Pharmacol Ther. 2017 Jul;102(1):37-44. doi: 10.1002/cpt.597. Epub 2017 Feb 13.
7
Application of a physiologically based pharmacokinetic model for the evaluation of single-point plasma phenotyping method of CYP2D6.基于生理药代动力学模型在评估CYP2D6单点血浆表型分析方法中的应用。
Eur J Pharm Sci. 2016 Sep 20;92:131-6. doi: 10.1016/j.ejps.2016.07.001. Epub 2016 Jul 10.
8
Prediction of CYP2D6 phenotype from genotype across world populations.全球不同人群中基于基因型对CYP2D6表型的预测。
Genet Med. 2017 Jan;19(1):69-76. doi: 10.1038/gim.2016.80. Epub 2016 Jul 7.
9
Alternative methods for CYP2D6 phenotyping: comparison of dextromethorphan metabolic ratios from AUC, single point plasma, and urine.CYP2D6 表型分析的替代方法:比较来自AUC、单点血浆和尿液的右美沙芬代谢率
Int J Clin Pharmacol Ther. 2016 May;54(5):330-6. doi: 10.5414/CP202387.
10
CYP2D6 and pharmacogenomics: where does future research need to focus? Part 2: clinical aspects.细胞色素P450 2D6与药物基因组学:未来研究需聚焦于何处?第二部分:临床方面。
Pharmacogenomics. 2014 Jun;15(8):1055-8. doi: 10.2217/pgs.14.27.